Aclarion Price to Book Ratio 2021-2024 | ACON
Historical price to book ratio values for Aclarion (ACON) over the last 10 years. The current price to book ratio for Aclarion as of May 06, 2025 is 0.14.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Aclarion Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-06 | 7.40 | 0.00 | |
| 2024-12-31 | 1302.48 | 0.00 | |
| 2024-09-30 | 1655.23 | $0.25 | 6618.29 |
| 2024-06-30 | 2586.87 | $0.20 | 12921.43 |
| 2024-03-31 | 2984.85 | $0.35 | 8513.55 |
| 2023-12-31 | 28944.00 | 0.00 | |
| 2023-09-30 | 47178.70 | $-0.10 | -468973.35 |
| 2023-06-30 | 99856.80 | $0.00 | 83213997.40 |
| 2023-03-31 | 94068.00 | $0.14 | 657358.49 |
| 2022-12-31 | 83937.60 | $4.53 | 18509.25 |
| 2022-09-30 | 112592.00 | $0.37 | 300325.84 |
| 2022-06-30 | 132274.00 | $0.54 | 244093.15 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.004B | $0.000B |
| Aclarion Inc. is a healthcare technology company which leverages Magnetic Resonance Spectroscopy and a proprietary biomarker to optimize clinical treatments. The Company is also researching the application of AI and machine learning platforms to analyze both the raw spectroscopy data and the post-processed signal to evaluate whether AI platforms. Aclarion Inc. is based in SAN MATEO, CA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.273B | 26.50 |
| Elevance Health (ELV) | United States | $94.057B | 12.14 |
| CVS Health (CVS) | United States | $84.883B | 10.55 |
| Cencora (COR) | United States | $56.618B | 20.55 |
| Natera (NTRA) | United States | $21.276B | 0.00 |
| DiDi Global (DIDIY) | China | $19.908B | 30.21 |
| BioMerieux (BMXMF) | France | $15.658B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.897B | 0.00 |
| Solventum (SOLV) | United States | $11.572B | 10.79 |
| ICON (ICLR) | Ireland | $11.550B | 10.74 |
| CochLear (CHEOY) | Australia | $11.542B | 0.00 |
| Revvity (RVTY) | United States | $11.153B | 18.83 |
| Doximity (DOCS) | United States | $11.088B | 57.66 |
| Viatris (VTRS) | United States | $10.187B | 3.24 |
| Medpace Holdings (MEDP) | United States | $8.637B | 22.94 |
| Avantor (AVTR) | United States | $8.606B | 12.51 |
| Sonic Healthcare (SKHHY) | Australia | $8.191B | 0.00 |
| HealthEquity (HQY) | United States | $7.908B | 38.90 |
| Charles River Laboratories (CRL) | United States | $5.866B | 11.57 |
| Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
| Bausch + Lomb (BLCO) | Canada | $4.018B | 23.69 |
| BrightSpring Health Services (BTSG) | United States | $3.685B | 34.11 |
| Sotera Health (SHC) | United States | $3.667B | 20.84 |
| Alignment Healthcare (ALHC) | United States | $3.063B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.009B | 34.51 |
| Concentras Parent (CON) | United States | $2.767B | 14.39 |
| Organon (OGN) | United States | $2.267B | 2.41 |
| Progyny (PGNY) | United States | $2.005B | 44.15 |
| Ardent Health Partners (ARDT) | United States | $1.880B | 0.00 |
| Premier (PINC) | United States | $1.873B | 11.99 |
| GeneDx Holdings (WGS) | United States | $1.857B | 72.70 |
| GoodRx Holdings (GDRX) | United States | $1.799B | 39.08 |
| Agilon Health (AGL) | United States | $1.702B | 0.00 |
| PACS (PACS) | United States | $1.536B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.254B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.111B | 9.32 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.967B | 0.00 | |
| CareDx (CDNA) | United States | $0.845B | 13.19 |
| AMN Healthcare Services Inc (AMN) | United States | $0.759B | 6.01 |
| Embecta (EMBC) | United States | $0.724B | 4.96 |
| Nutex Health (NUTX) | United States | $0.720B | 14.10 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.516B | 13.67 |
| Sonida Senior Living (SNDA) | United States | $0.447B | 0.00 |
| Enhabit (EHAB) | United States | $0.404B | 37.95 |
| InnovAge Holding (INNV) | United States | $0.391B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.375B | 0.00 |
| LifeMD (LFMD) | United States | $0.332B | 0.00 |
| SBC Medicals (SBC) | United States | $0.320B | 0.00 |
| DocGo (DCGO) | United States | $0.240B | 9.79 |
| Oncology Institute (TOI) | United States | $0.200B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.186B | 0.00 |
| Beauty Health (SKIN) | United States | $0.133B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.105B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.090B | 0.00 |
| So-Young (SY) | China | $0.085B | 0.00 |
| OncoCyte (OCX) | United States | $0.084B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.078B | 0.00 |
| Biodesix (BDSX) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.025B | 0.00 |
| ModivCare (MODV) | United States | $0.020B | 7.05 |
| KindlyMD (KDLY) | United States | $0.016B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |